Analysis: Shire’s market value settles at well below bid value

Country

Ireland

After Shire Plc rejected a cash and stock offer of about $63 billion from Takeda Pharmaceutical Co and Allergan Plc reconsidered its statement that it was considering an offer for Dublin-based company, Shire’s market value settled at around $48.4 billion in trading Friday, reflecting investor’s disbelief that a higher bid might be in the offing